Get the Stockscreener App
1.77
2.31%
0.04
After Hours:
1.76
-0.01
-0.56%
Icad Inc stock is traded at $1.77, with a volume of 401.71K.
It is up +2.31% in the last 24 hours and down -9.69% over the past month.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.
See More
Previous Close:
$1.73
Open:
$1.72
24h Volume:
401.71K
Relative Volume:
1.96
Market Cap:
$44.67M
Revenue:
$20.46M
Net Income/Loss:
$-4.85M
P/E Ratio:
-3.6122
EPS:
-0.49
Net Cash Flow:
$-6.23M
1W Performance:
+14.56%
1M Performance:
-9.69%
6M Performance:
+12.03%
1Y Performance:
+29.20%
1-Day Range:
$1.61
$1.7845
1-Week Range:
$1.49
$1.88
52-Week Range:
$1.18
$2.6499
Icad Inc Stock (ICAD) Company Profile
Name
Icad Inc
Sector
Industry
Phone
603-882-5200
Address
98 SPIT BROOK ROAD, SUITE 100, NASHUA, NH
Compare ICAD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICAD
Icad Inc
|
1.77 | 44.67M | 20.46M | -4.85M | -6.23M | -0.49 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Icad Inc Stock (ICAD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-18-22 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-22-21 | Initiated | Guggenheim | Buy |
| Mar-23-21 | Initiated | BTIG Research | Buy |
| Feb-26-21 | Initiated | Oppenheimer | Outperform |
| Jan-29-21 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-03-20 | Initiated | B. Riley Securities | Buy |
| Feb-05-20 | Initiated | JMP Securities | Mkt Outperform |
| Jan-09-20 | Initiated | Lake Street | Buy |
| Dec-09-08 | Reiterated | Canaccord Adams | Buy |
| Aug-01-08 | Reiterated | MDB Capital Group | Buy |
| May-14-08 | Reiterated | Canaccord Adams | Buy |
| Feb-14-08 | Initiated | Sun Trust Rbsn Humphrey | Buy |
| Jan-24-07 | Reiterated | Dawson James | Speculative Buy |
View All
Icad Inc Stock (ICAD) Latest News
iCAD Advances Fight Against Breast Cancer with FDA-cleared, - GlobeNewswire
iCAD's New AI Cancer Detection System Boosts Accuracy by 22%, Partners with Cascaid Health | ICAD Stock News - StockTitan
U.S. Computer-Aided Detection (CAD) Market Future Business - openPR
Computer Aided Detection (CAD) Market: Expected Positive - openPR
Need To Know: Analysts Just Made A Substantial Cut To Their iCAD, Inc. (NASDAQ:ICAD) Estimates - Yahoo Finance
iCAD Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
iCAD, Inc. (NASDAQ:ICAD) Q3 2024 Earnings Call Transcript - Insider Monkey
iCAD (NASDAQ:ICAD) Rating Lowered to “Sell” at StockNews.com - Defense World
ICAD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Earnings call: iCAD reports steady growth with SaaS transition By Investing.com - Investing.com Canada
Q3 2024 ICAD Inc Earnings Call - Cbainfo
iCad Inc. (ICAD) Quarterly 10-Q Report - Quartzy
Icad: Q3 Earnings Snapshot - New Haven Register
iCAD (NASDAQ:ICAD) Shares Pass Above 200-Day Moving AverageWhat's Next? - MarketBeat
icad Inc (ICAD) Q3 2024 Earnings Call Highlights: Revenue Growth Amidst Strategic Shifts - GuruFocus.com
iCAD, Inc. Reports Growth in ARR and Revenue - TipRanks
iCAD reports Q3 adjusted EPS (7c), consensus (8c) - TipRanks
iCAD Inc Reports Q3 2024 Revenue of $4.2 Million, EPS Loss of $0 - GuruFocus.com
iCAD Reports Financial Results for Third Quarter Ended September 30, 2024 - GlobeNewswire
iCAD Q3 Revenue Grows 4%, Secures FDA Clearance for Enhanced Cancer Detection Tech | ICAD Stock News - StockTitan
iCAD AI breast cancer detection tool gains FDA approval By Investing.com - Investing.com Australia
FDA clears AI-powered breast cancer detection tech from iCad - Mass Device
iCAD announces ProFound Detection for DBT received clearance from FDA - TipRanks
iCAD's ProFound Detection Version 4.0 Gets FDA Clearance - Imaging Technology News
iCAD AI breast cancer detection tool gains FDA approval - Investing.com
iCAD's ProFound Detection Version 4.0 Gains FDA Clearance - GlobeNewswire
iCAD's AI Cancer Detection Gets FDA Nod, Shows 60% Better Accuracy in Key Areas | ICAD Stock News - StockTitan
iCAD, Inc. (NASDAQ:ICAD) Looks Just Right With A 47% Price Jump - Simply Wall St
Volpara, DHA Sign Deal to Modernize Mammography Services - Imaging Technology News
iCAD to Attend 15th Annual Craig-Hallum Alpha Select Conference - GlobeNewswire
iCAD to Present at Craig-Hallum Conference: AI Healthcare Leader Meets Institutional Investors | ICAD Stock News - StockTitan
iCAD to Report Third Quarter 2024 Financial Results on November 13, 2024 - GlobeNewswire
icad (ICAD) Cash, Cash Equivalents, Marketable Securities : $20.35 Mil (As of Jun. 2024) - GuruFocus.com
Computer Aided Detection Market Is Booming Worldwide 2024-2031 - openPR
iCAD (NASDAQ:ICAD) Share Price Crosses Above 200-Day Moving AverageTime to Sell? - MarketBeat
iCAD (NASDAQ:ICAD) Share Price Passes Above 200-Day Moving Average – Here’s What Happened - Defense World
ICAD, Inc. (ICAD): A Bull Case Theory - Insider Monkey
3 US Penny Stocks With Market Caps At Least $40M To Watch - Simply Wall St
iCAD (NASDAQ:ICAD) adds US$15m to market cap in the past 7 days, though investors from three years ago are still down 82% - Simply Wall St
iCAD (NASDAQ:ICAD) Stock Crosses Above 200 Day Moving AverageTime to Sell? - MarketBeat
iCAD to Participate in the LD Micro Main Event XVII - The Sudbury Star
icad Inc (ICAD) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Shifts - Yahoo Finance
Breast Cancer Brachytherapy Market Growth Report | Elekta, Varian Medical Systems, ICAD, Hologic, Cianna Medical - Times-BD24
iCAD Highlights Global Availability of ProFound Cloud and International Expansion Milestones at JFR 2024 - GlobeNewswire
New Research Finds iCAD's ProFound AI Risk for Digital Breast Tomosynthesis is 2.4x More Accurate than Traditional Lifetime Risk Models - Barchart
Siemens Healthineers Receives FDA Premarket Approval for 3D Portion of Mammography System - Imaging Technology News
iCAD (NASDAQ:ICAD) Stock Price Passes Above 200 Day Moving Average of $1.50 - Defense World
Intraoperative Radiation Therapy Market Present Scenario of Manufacturers – ZEISS Group, iCAD, IntraOp Medical Corporation, Ariane Medical Systems – Cauverynews - Cauverynews
Icad Inc Stock (ICAD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):